/ /

  • linkedin
  • Increase Font
  • Sharebar

    Drug delivery systems could improve poor adherence

    Intraocular drug delivery systems could help solve the problem of poor adherence in patients taking glaucoma medications, according to Jonathan S. Myers, MD.

    Implanted in the eye, intraocular drug delivery systems for glaucoma drugs gradually dissolve or elute medication, relieving the patient of a daily regimen that can be difficult psychologically and physically.

    "Patients don't want to be reminded every day that they have a potentially blinding disease," said Dr. Myers, co-director, Glaucoma Service, Wills Eye Hospital, Philadelphia.

    Dr. Myers described three devices now in clinical trials–the Bimatoprost SR (Allergan), the ENV515 (EnvisiaTherapeutics), and the iDose (Glaukos).


    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results